title: The outcome of 5-ALA-mediated photodynamic treatment in melanoma cells is influenced by vitamin C and heme oxygenase-1.
abstract: Photodynamic therapy (PDT) is an important clinical approach for cancer treatment. It involves the administration of a photosensitizer, followed by its activation with light and induction of cell death. The underlying mechanism is an increased production of reactive oxygen species (ROS) leading to oxidative stress, which is followed by cell death. However, effectiveness of PDT is limited due to an initiation of endogenous rescue response systems like heme oxygenase-1 (HO-1) in tumor cells. In recent years, consuming of antioxidant supplements has become widespread, but the effect of exogenously applied antioxidants on cancer therapy outcome remains unclear. Thus, this study was aimed to investigate if exogenous antioxidants might decrease ROS-induced cytotoxicity in photodynamic treatment. Lycopene, β-carotene, vitamin C, N-acetylcysteine, trolox, and N-tert-butyl-α-phenylnitrone in different doses were administered to human melanoma cells prior exposure to photodynamic treatment. Supplementation with vitamin C resulted in a significant decrease of the cell death rate, whereas the other tested antioxidants had no effect on cell viability and oxidative stress markers. The simultaneous application of vitamin C with the HO-1 activity inhibitor zinc protoporphyrine IX (ZnPPIX) caused a considerable decrease of photodynamic treatment-induced cytotoxicity compared to ZnPPIX alone. It can be summarized that exogenously applied antioxidants do not have a leading role in the protective response against photodynamic treatment. However, further studies are necessary to investigate more antioxidants and other substances, which might affect the outcome of photodynamic treatment in cancer therapy.
authors.affiliation: Institute of Nutrition, Friedrich Schiller University of Jena, Dornburger Strasse 24, Jena, Germany.
authors.forename: Stefanie
authors.initials: S
authors.lastname: Grimm
authors.forename: Dagmar
authors.initials: D
authors.lastname: Mvondo
authors.forename: Tilman
authors.initials: T
authors.lastname: Grune
authors.forename: Nicolle
authors.initials: N
authors.lastname: Breusing
mesh_terms: D000622:Aminolevulinic Acid / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D051547:Heme Oxygenase-1 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology*; D018384:Oxidative Stress; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000494:pharmacology*; D011524:Protoporphyrins / Q000494:pharmacology; D015854:Up-Regulation
chemical_list: D000975:Antioxidants; D017319:Photosensitizing Agents; D011524:Protoporphyrins; C017803:zinc protoporphyrin; D000622:Aminolevulinic Acid; C496541:HMOX1 protein, human; D051547:Heme Oxygenase-1; D001205:Ascorbic Acid